- Clive Grattan, Norfolk and Norwich University Hospital
Clinical and Translational Allergy is one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology.
Clive Grattan, MA, MD, FRCP, is currently Consultant Dermatologist at the Norfolk and Norwich University Hospital and St John's Institute of Dermatology, London, UK. Since 2011 he is also Chair of the Dermatology Section of the Academy of Allergy and Clinical Immunology (EAACI), the academic association behind this journal.
"Clinical and Translational Allergy is a pioneering initiative to make high quality peer-reviewed research and reviews in Allergy and related subjects available to clinicians, scientists and the public in an open-access format. Authors retain copyright of their material. The journal is now indexed in PubMed Central and new publications will therefore have wide exposure. Advances in allergy and immunology are being made in the clinic and in the laboratory at a rapid rate. CTA provides the platform for rapid dissemination of these findings to a wide audience to provide greatest impact and benefit to society. The challenge of launching a new journal is already past and now is the time to project CTA into the future as the premier online resource for allergy research."
Aims & scope
Clinical and Translational Allergy is a peer-reviewed, open access journal providing a platform to publish original research and reviews in the field of allergy. Such articles can be based on clinical, translational or basic research.
Clinical and Translational Allergy is one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology. Open access publishing enables free access to all contents ensuring a wide dissemination of articles; the electronic format and the optimised manuscript handling process allows very rapid publication of papers.
Clinical and Translational Allergy is an international journal reaching out far beyond the borders of Europe, and invites clinicians and researchers from all countries of the world to contribute. Clinical and Translational Allergy publishes original research articles and reviews, as well as EAACI position articles, EAACI Task Force Reports and EAACI guidelines.
Notice for EAACI members
EAACI has provided limited funds to cover the APC on behalf of EAACI members submitting manuscripts to Clinical and Translational Allergy in 2012.
Please contact Managing Editor Dr Vicky Cardona to request funds for your submission.
Article collection: Advances in food allergy
Clinical and Translational Allergy is participating in a cross-journal article collection that brings together articles on all aspects of food allergy. View (and bookmark) the articles already published here. To contribute a new article to the series, submit your manuscript to the journal quoting your interest in the series in your cover letter.
The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organization active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was founded in 1956 in Florence and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 7,400 members from 121 countries, as well as 42 National Allergy Societies.
EAACI's mission is to promote basic and clinical research; to collect, assess and diffuse scientific information; to act as a scientific reference body for other scientific, health and political organisations; to encourage and provide training and continuous education, and to collaborate with patients and lay organisations.
The Academy aims to provide the most efficient platform for scientific communication and education in the field of allergy and immunology, ultimately striving to ease patients' lives.
For more information please visit www.eaaci.org
Volume 3 Suppl 3 (25 July 2013)
Nice, France. 7-9 February 2013
Volume 3 Suppl 2 (16 July 2013)
Leuven, Belgium. 21-23 March 2013